» Articles » PMID: 11438448

Circulating Breast Cancer Cells Are Frequently Apoptotic

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2001 Jul 5
PMID 11438448
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

Automatic search for cytokeratin/mucin-1 double immunofluorescence was performed to detect and characterize circulating epithelial tumor cells in patients with advanced breast cancer. The peripheral blood samples in 8 of 19 patients (42.1%) presented with cytokeratin-positive and epithelial-type mucin-positive (CK(+)/MUC1(+)) tumor cells. Detailed microscopic analysis, however, suggested that the majority of the double immunopositive cells was apoptotic according to an "inclusion type" cytokeratin staining pattern and nuclear condensation. Furthermore, apoptosis-related DNA strand breaks could be demonstrated by applying the TdT-uridine nick end labeling assay in these cells. In 3 of 8 positive samples all of the CK(+)/MUC1(+) cells displayed apoptotic features. We conclude that apoptotic cells significantly contribute to the circulating tumor cell fraction in breast cancer patients. As the predictive value of such cells for the outcome of the disease is unclear, they should be considered separately when analyzing tumor cell dissemination.

Citing Articles

Peripheral arterial rather than venous blood is a better source of circulating tumor cells in early lung cancer.

Wang Z, Feng Y, Wang Y, Ma Y, Liu J, Li D Thorac Cancer. 2024; 15(8):654-660.

PMID: 38297462 PMC: 10928244. DOI: 10.1111/1759-7714.15236.


Zwitterionic microgel preservation platform for circulating tumor cells in whole blood specimen.

Ma Y, Zhang J, Tian Y, Fu Y, Tian S, Li Q Nat Commun. 2023; 14(1):4958.

PMID: 37587113 PMC: 10432405. DOI: 10.1038/s41467-023-40668-1.


Relationship of Ki-67 index in biopsies of metastatic breast cancer tissue and circulating tumor cells (CTCs) at the time of biopsy collection.

Deutsch T, Fischer C, Riedel F, Hassdenteufel K, Michel L, Sutterlin M Arch Gynecol Obstet. 2023; 309(1):235-248.

PMID: 37480379 PMC: 10769933. DOI: 10.1007/s00404-023-07080-y.


Circulating biomarkers in oral cancer: Unravelling the mystery.

Prakash N, Pradeep G J Oral Maxillofac Pathol. 2023; 26(3):300-306.

PMID: 36588829 PMC: 9802512. DOI: 10.4103/jomfp.jomfp_338_22.


Prognostic Role of Circulating Tumor Cells in the Pulmonary Vein, Peripheral Blood, and Bone Marrow in Resectable Non-Small Cell Lung Cancer.

Lee J, Jung W, Yum S, Lee J, Cho S J Chest Surg. 2022; 55(3):214-224.

PMID: 35440519 PMC: 9178304. DOI: 10.5090/jcs.21.140.


References
1.
Diel I, Kaufmann M, Costa S, Holle R, von Minckwitz G, Solomayer E . Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst. 1996; 88(22):1652-8. DOI: 10.1093/jnci/88.22.1652. View

2.
Pantel K, Izbicki J, Passlick B, Angstwurm M, Haussinger K, Thetter O . Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet. 1996; 347(9002):649-53. DOI: 10.1016/s0140-6736(96)91203-9. View

3.
Ku N, Liao J, Omary M . Apoptosis generates stable fragments of human type I keratins. J Biol Chem. 1998; 272(52):33197-203. DOI: 10.1074/jbc.272.52.33197. View

4.
Mori M, Mimori K, Ueo H, Tsuji K, Shiraishi T, Barnard G . Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol. 1998; 16(1):128-32. DOI: 10.1200/JCO.1998.16.1.128. View

5.
Funaki N, Tanaka J, Ohshio G, Onodera H, Maetani S, Imamura M . Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients. Br J Cancer. 1998; 77(8):1327-32. PMC: 2150160. DOI: 10.1038/bjc.1998.221. View